Page last updated: 2024-08-24

1,5-anhydroglucitol and Non-alcoholic Fatty Liver Disease

1,5-anhydroglucitol has been researched along with Non-alcoholic Fatty Liver Disease in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Chayama, K; Hashiba, M; Hirose, A; Hyogo, H; Ikeda, Y; Ishikawa, Y; Masuda, K; Munekage, K; Nagata, Y; Noguchi, S; Nozaki-Fujimura, Y; Ochi, T; Okamoto, N; Ono, M; Saibara, T; Suganuma, N; Yoshioka, R	1

Other Studies

1 other study(ies) available for 1,5-anhydroglucitol and Non-alcoholic Fatty Liver Disease

Article	Year
Glycemic variability is an independent predictive factor for development of hepatic fibrosis in nonalcoholic fatty liver disease. PloS one, 2013, Volume: 8, Issue:11 Topics: Adult; Aged; Blood Glucose; Deoxyglucose; Disease Progression; Fatty Liver; Female; Glycated Hemoglobin; Humans; Insulin; Insulin Secretion; Liver Cirrhosis; Male; Middle Aged; Multivariate Analysis; Non-alcoholic Fatty Liver Disease; Prognosis	2013

Article

Year

Glycemic variability is an independent predictive factor for development of hepatic fibrosis in nonalcoholic fatty liver disease.

PloS one, 2013, Volume: 8, Issue:11

Topics: Adult; Aged; Blood Glucose; Deoxyglucose; Disease Progression; Fatty Liver; Female; Glycated Hemoglobin; Humans; Insulin; Insulin Secretion; Liver Cirrhosis; Male; Middle Aged; Multivariate Analysis; Non-alcoholic Fatty Liver Disease; Prognosis

2013